Human Microbiome: A Vision For the Future of Biotechnology Research
The Human Microbiome Project of the
National Institutes of Health in the United States and related international
efforts are defining the varieties of a normal microbiome, studying how changes
in the microbiota relate to disease. Large governmental research initiatives
including the Human Microbiome Project in the U.S. have accelerated research on
the human microbiome.
Also, many companies are designing and
developing many microbiome therapies. For instance, Rebiotix Inc. has developed
Microbiota Restoration Therapy (MRT) drug platform which is the drug platform
for delivering healthy, live, human-derived microbes into a sick patient’s
intestinal tract to treat disease. Thus, the increasing focus on human
microbiome therapies is the prime factor driving the growth of human microbiome
market in the coming years.
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
US is anticipated to lead the adoptions of
Human microbiome across the North American region through the forecast period.
The application of the human microbiome are beneficial for various treatment
areas such as cancer, Inflammatory Bowel Disease (IBD), diabetes, autoimmune
diseases and more. To be specific with the applications of the human
microbiome, it plays important role in the developments in wide range of
diseases and disorders which includes cardiovascular disease, cancer,
autoimmune, neurological disorders and more. Therefore, various programs are
being organized in the country to grow the awareness of probiotics and
prebiotics in order to enhance the human microbiome.
Comments
Post a Comment